BioHarvest - BHST Operating Margin

Corporate emblem and logo of BioHarvest Sciences Inc. (BHST)

BioHarvest Sciences specializes in the cellular synthesis of polyphenols for cosmetics and nutraceuticals, utilizing a unique method for resveratrol extraction. The EBIT margin reflects the profitability of core operations, with the current value of the metric standing at -24.80. The optimization of plant locations minimizes transportation costs for biomass. The commercialization of the bio-cellular platform creates sustainable operational momentum, strengthening the company's financial health.

BioHarvest Sciences, Inc. (BHST): Operating Profit Rate from 11/13/2024 to 11/19/2026

Metric breakdowns and analytics for bioharvest.com (BHST)

- share price and consensus valuation forecast:
Initial company analysis:BioHarvest Sciences Inc.
Finished products of BioHarvest Sciences

BioHarvest Sciences operates in the high-risk cellular agriculture sector. Operating margin measures the efficiency of the core business, excluding the impact of taxes and debt load. Analyzing the current operating margin allows for an assessment of real production profitability, disregarding one-off market fluctuations. For biotech, this indicator is critical when scaling plants and introducing new products. Steady growth in this metric would confirm the fundamental stability of the model.

Direct competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.